+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Virology"

Immunofluorescence Assay Market Report 2025 - Product Thumbnail Image

Immunofluorescence Assay Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Viral Sensitizers - Global Strategic Business Report - Product Thumbnail Image

Viral Sensitizers - Global Strategic Business Report

  • Report
  • February 2026
  • 274 Pages
  • Global
From
Virology and Bacteriology - Global Strategic Business Report - Product Thumbnail Image

Virology and Bacteriology - Global Strategic Business Report

  • Report
  • February 2026
  • 279 Pages
  • Global
From
From
From
From
Glycobiology Market Report and Forecast 2025-2034 - Product Thumbnail Image

Glycobiology Market Report and Forecast 2025-2034

  • Report
  • July 2025
  • 350 Pages
  • Global
From
From
From
From
From
From
From
From
From
Cell Counting Market Overview, 2025-30 - Product Thumbnail Image

Cell Counting Market Overview, 2025-30

  • Report
  • June 2025
  • 105 Pages
  • Global
From
From
Loading Indicator

Virology is a branch of biotechnology that focuses on the study of viruses and their effects on living organisms. It involves the study of the structure, function, and genetics of viruses, as well as their interactions with hosts. Virology also involves the development of vaccines and antiviral drugs to prevent and treat viral infections. Virology has become increasingly important in recent years due to the emergence of new and emerging viral diseases, such as Zika, Ebola, and SARS-CoV-2. Virologists are also involved in the development of gene therapy and gene editing technologies, which have the potential to revolutionize the treatment of many diseases. The virology market is highly competitive, with many companies offering products and services related to the study and treatment of viruses. Some of the major players in the market include Merck & Co., GlaxoSmithKline, Pfizer, Sanofi, Novartis, and Johnson & Johnson. Other companies in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, and Gilead Sciences. Show Less Read more